Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Sartorius stock

SRT.DE
DE0007165607
716560

Price

175.80
Today +/-
+0
Today %
+0 %

Sartorius stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Sartorius stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Sartorius stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Sartorius stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Sartorius's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Sartorius Stock Price History

DateSartorius Price
12/18/2024175.80 undefined
12/17/2024175.80 undefined
12/16/2024180.00 undefined
12/13/2024182.00 undefined
12/12/2024188.00 undefined
12/11/2024187.00 undefined
12/10/2024184.60 undefined
12/9/2024175.40 undefined
12/6/2024174.40 undefined
12/5/2024172.80 undefined
12/4/2024177.40 undefined
12/3/2024175.20 undefined
12/2/2024181.00 undefined
11/29/2024179.60 undefined
11/28/2024180.00 undefined
11/27/2024178.40 undefined
11/26/2024176.80 undefined
11/25/2024176.60 undefined
11/22/2024175.80 undefined
11/21/2024168.00 undefined
11/20/2024170.20 undefined
11/19/2024170.00 undefined

Sartorius Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sartorius, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sartorius from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sartorius’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sartorius. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sartorius’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sartorius’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sartorius’s growth potential.

Sartorius Revenue, EBIT and net profit per share

DateSartorius RevenueSartorius EBITSartorius Net Income
2029e5.4 B undefined1.24 B undefined783.17 M undefined
2028e4.95 B undefined1.09 B undefined697.06 M undefined
2027e4.47 B undefined937.36 M undefined578.45 M undefined
2026e4.07 B undefined833.2 M undefined503.45 M undefined
2025e3.68 B undefined678.03 M undefined398.47 M undefined
2024e3.4 B undefined539.6 M undefined308.86 M undefined
20233.4 B undefined543.3 M undefined205.2 M undefined
20224.17 B undefined1.14 B undefined678.1 M undefined
20213.45 B undefined933.3 M undefined318.9 M undefined
20202.34 B undefined511.32 M undefined210.1 M undefined
20191.83 B undefined363.36 M undefined156.69 M undefined
20181.57 B undefined300.62 M undefined141.34 M undefined
20171.4 B undefined262.96 M undefined114.73 M undefined
20161.3 B undefined247.67 M undefined102.93 M undefined
20151.11 B undefined211.65 M undefined126.3 M undefined
2014891.17 M undefined130.08 M undefined48.49 M undefined
2013887.3 M undefined124.2 M undefined52.4 M undefined
2012845.7 M undefined137.2 M undefined48.5 M undefined
2011733.1 M undefined121.1 M undefined50.5 M undefined
2010659.3 M undefined85.5 M undefined31 M undefined
2009602.1 M undefined30.9 M undefined-7.3 M undefined
2008611.6 M undefined56.8 M undefined12.4 M undefined
2007589 M undefined59.2 M undefined30.1 M undefined
2006521.1 M undefined52.1 M undefined29 M undefined
2005484.3 M undefined43.7 M undefined22.1 M undefined
2004467.6 M undefined34.9 M undefined15.2 M undefined

Sartorius Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0.220.240.250.280.430.450.480.440.470.480.520.590.610.60.660.730.850.890.891.111.31.41.571.832.343.454.173.43.43.684.074.474.955.4
-7.806.3810.8054.514.916.01-7.145.663.647.6413.053.74-1.479.4711.2315.284.970.4525.0316.708.0011.5416.6027.8847.7121.02-18.660.038.2410.759.7810.819.01
73.3974.4775.2078.3470.5668.8243.7046.1546.0446.6947.0246.1846.8145.1847.9548.7049.7048.3747.3649.4648.5450.2851.2851.5351.6553.2952.1846.1646.1442.6338.4935.0631.6429.03
0.160.180.190.220.30.310.210.20.220.230.250.270.290.270.320.360.420.430.420.550.630.710.80.941.211.842.181.57000000
057923441522293012-73150485248126102114141156210318678205308398503578697783
--40.0028.57-77.7850.0033.33-275.0046.6731.823.45-60.00-158.33-542.8661.29-4.008.33-7.69162.50-19.0511.7623.6810.6434.6251.43113.21-69.7650.2429.2226.3814.9120.5912.34
----------------------------------
----------------------------------
74.974.974.974.974.969.268.268.268.268.268.268.268.268.268.268.268.268.268.1968.3968.3968.3968.3968.3968.3968.4268.4268.42000000
----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Sartorius Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Sartorius is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
15.215.570.847.726181496.79.9817.721.958.627.74139.57252.1964.5772.0774.6867.3466.88217.65360.99196.8415.9
39.441.345.865.492.4107.4100.590.193.3103.7110.9131.7125.18395.6111.1117.1134.5140.37193.03241.24282.21307.36302.72314.26423.99484.5350.6
0000000001.83.515.813.56.15.24.68.914.111.0512.0326.2230.1819.0923.4527.9434.239.260.5
0.040.040.040.060.090.080.070.070.070.070.070.090.10.070.080.10.130.140.150.190.220.250.320.410.560.891.181.04
5.755.37.112.915.713.39.510.67.88.910.715.515.616.81923.34.386.5517.9625.9138.8438.4645.392.1884.79123.793.2
0.10.10.160.180.220.220.20.180.180.190.20.260.270.230.220.280.320.360.440.480.590.670.750.851.211.82.021.96
0.040.040.040.050.070.140.140.130.120.120.120.150.160.150.150.180.210.230.250.320.390.510.660.830.971.311.712.08
1.71.41.52.51.31.93.43.23.133.83.45.15.75.88.24.66.37.748.117.5120.1528.7830.0134.1260.85150.9114.8
0000000000000000.1000000016.415.242930.80
0000000.010.010.010.010.010.110.120.110.110.140.170.180.170.210.270.430.40.430.991.11.282.06
000.010.010.030.030.020.030.020.020.020.240.290.290.290.330.350.370.380.410.470.650.660.71.231.361.723.45
2.43.13.44.56.221.922.723.218.820.114.613.417.624.526.13127.728.822.6119.6728.6116.2821.2827.2546.5576.7886.787.5
0.050.050.050.070.110.190.20.190.180.170.180.520.590.590.590.690.760.810.840.961.171.631.772.033.293.934.997.79
0.150.150.210.250.320.410.40.370.360.370.380.780.860.820.810.961.071.171.271.441.752.32.532.884.55.737.019.75
                                                       
12.812.818.418.718.71717171717171717171717171717.0517.168.3968.3968.3968.3968.4268.4268.468.4
36.236.2101.4101.4101.48787878787878787878787878787.0488.3538.4239.6640.1640.6941.9943.3144.645.2
0.010.010.020.020.020.030.030.020.030.040.060.190.190.170.170.20.250.280.310.410.470.510.640.7111.171.861.95
1.31.31.31.51.500000000000-17.1-20.8-13.775.76-0.69-3.55-7.79-8.77-76.24-17.4420.70.1
0000000000000000000000000000
0.060.060.140.140.140.140.130.130.140.150.170.290.290.270.280.310.330.370.40.520.580.620.740.811.031.261.992.07
5.45.87.214.418.127.22422.128.324.428.338.140.136.746.841.846.375.556.3970.7575.6391.64120.39140.78188.78281.9303306.5
0000000000000000031.256.2460.6465.5373.8587.6995.1132.34208.39166.592.3
16.710.78.39.520.242.333.532.735.959.658.269.5168.198.3117.6139.4137.878.893.6791.45127.22160.61162.64239.23354.49719.42778.9643.2
0000000000000000000000000000
20.421.319.725.277.4132.291.194.783.727.833.9193.746.821.918.148.896.728.242.6148.1295.9967.57109.98187.51195.48337.47555288
0.040.040.040.050.120.20.150.150.150.110.120.30.260.160.180.230.280.210.250.270.360.390.480.660.871.551.81.33
0.020.010.01000.010.060.0200.040.030.010.190.260.210.280.290.40.420.410.520.930.890.881.891.741.995.02
687.698.4013.114.314.31313.441.14037.938.337.832.33729.7633.4254.3392.0583.6890.69120.38182.04235.2442.3
25.426.428.245.552.253.846.25456.350.646.193.743.94553.254.866.169.975.2174.6282.173.8494.46141.12221.09510.53294191.9
0.050.050.040.060.060.070.120.090.070.110.090.150.280.340.30.370.390.510.530.520.651.11.071.112.232.432.525.66
0.090.080.080.110.180.270.260.240.220.220.210.450.530.50.480.60.670.720.780.791.021.491.551.783.13.984.326.99
0.150.150.210.250.320.410.40.370.360.370.380.740.820.770.760.911.091.171.311.62.112.292.594.145.246.319.06
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Sartorius provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Sartorius's financial health and stability.

Assets

Sartorius's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Sartorius must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Sartorius after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Sartorius's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.010.010.0100.010.010.010.020.030.040.040.01-0.010.030.050.060.10.10.210.20.20.270.30.450.671.180.39
101012172022232218192729333132404754587598113132180231287342
000000000000000000000000000
2-6-3-33-8-480-11-16-37-2273-2-39-87-61-58-131-125-112-137-89-127-271-6213
00-6-3779756434433533351513-151621-23311237-112121
000056548614141151081213119172327253135107
000034379132812414234937324665546969120189239154
191211-152533485143513353143967953103113125170206244379511866734853
-5-9-15-28-71-29-9-9-9-23-33-24-15-15-38-41-56-86-111-148-197-233-225-240-407-522-559
-5-15-23-58-74-33-14-14-11-31-114-44-128-22-122-54-101-86-91-268-555-242-268-1,270-569-1,129-2,823
0-6-8-30-3-3-5-5-2-7-80-20-112-6-83-13-45020-119-357-9-43-1,030-162-607-2,263
000000000000000000000000000
-0.01-0.01-0.010.050.070.01-0.03-0.03-0.02-0.010.120.030.04-0.060.080.030.04-0.0100.150.410.05-0.010.99-0.070.42.49
07000-60000000000000000000000
-0.010.06-0.010.040.05-0-0.04-0.04-0.03-0.020.09-00.02-0.10.0500.01-0.04-0.040.10.35-0.02-0.10.91-0.170.212.17
-----5.00-3.00-3.00-4.00-8.00-6.00-13.00-23.00-15.00-39.00-12.00-12.00-16.00-18.00-24.00-18.00-27.00-31.00-46.00-57.00-42.00-109.00-230.00
0-2-4-4-4-4-4-4-7-8-10-11-7-7-10-13-16-17-18-25-31-34-42-24-48-85-98
055-23-311-3-5-23-19436-3013-112-11-39-2-149148139-177213
13.53-3.3-43.9-46.14.339.441.534.627.9-0.728.4127.680.240.111.647.327.6713.9321.669.4111.34154.1271.27458.99211.6293.9
000000000000000000000000000

Sartorius stock margins

The Sartorius margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sartorius. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sartorius.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sartorius's sales revenue. A higher gross margin percentage indicates that the Sartorius retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sartorius's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sartorius's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sartorius's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sartorius. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sartorius's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sartorius Margin History

Sartorius Gross marginSartorius Profit marginSartorius EBIT marginSartorius Profit margin
2029e46.15 %22.93 %14.51 %
2028e46.15 %22.07 %14.08 %
2027e46.15 %20.97 %12.94 %
2026e46.15 %20.47 %12.37 %
2025e46.15 %18.44 %10.84 %
2024e46.15 %15.89 %9.09 %
202346.15 %16 %6.04 %
202252.17 %27.3 %16.24 %
202153.31 %27.06 %9.25 %
202051.65 %21.89 %9 %
201951.51 %19.89 %8.58 %
201851.31 %19.2 %9.03 %
201750.32 %18.72 %8.17 %
201648.59 %19.05 %7.92 %
201549.5 %18.99 %11.33 %
201447.44 %14.6 %5.44 %
201348.42 %14 %5.91 %
201249.66 %16.22 %5.73 %
201148.75 %16.52 %6.89 %
201047.96 %12.97 %4.7 %
200945.23 %5.13 %-1.21 %
200846.83 %9.29 %2.03 %
200746.3 %10.05 %5.11 %
200647.15 %10 %5.57 %
200546.69 %9.02 %4.56 %
200446.15 %7.46 %3.25 %

Sartorius Stock Sales Revenue, EBIT, Earnings per Share

The Sartorius earnings per share therefore indicates how much revenue Sartorius has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sartorius earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sartorius's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sartorius’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sartorius's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sartorius Revenue, EBIT and net profit per share

DateSartorius Sales per ShareSartorius EBIT per shareSartorius Earnings per Share
2029e72.09 undefined0 undefined10.46 undefined
2028e66.13 undefined0 undefined9.31 undefined
2027e59.68 undefined0 undefined7.73 undefined
2026e54.37 undefined0 undefined6.72 undefined
2025e49.09 undefined0 undefined5.32 undefined
2024e45.35 undefined0 undefined4.12 undefined
202349.63 undefined7.94 undefined3 undefined
202261.02 undefined16.66 undefined9.91 undefined
202150.42 undefined13.64 undefined4.66 undefined
202034.15 undefined7.48 undefined3.07 undefined
201926.71 undefined5.31 undefined2.29 undefined
201822.9 undefined4.4 undefined2.07 undefined
201720.54 undefined3.85 undefined1.68 undefined
201619.01 undefined3.62 undefined1.51 undefined
201516.3 undefined3.09 undefined1.85 undefined
201413.07 undefined1.91 undefined0.71 undefined
201313.01 undefined1.82 undefined0.77 undefined
201212.4 undefined2.01 undefined0.71 undefined
201110.75 undefined1.78 undefined0.74 undefined
20109.67 undefined1.25 undefined0.45 undefined
20098.83 undefined0.45 undefined-0.11 undefined
20088.97 undefined0.83 undefined0.18 undefined
20078.64 undefined0.87 undefined0.44 undefined
20067.64 undefined0.76 undefined0.43 undefined
20057.1 undefined0.64 undefined0.32 undefined
20046.86 undefined0.51 undefined0.22 undefined

Sartorius business model

Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius is one of the most popular companies on Eulerpool.com.

Sartorius SWOT Analysis

Strengths

Sartorius AG has established a reputable brand image in the industry, known for its high-quality products and innovative solutions. This enables the company to attract and retain a loyal customer base.

Sartorius AG offers a wide range of products that cater to various industries, including biotechnology, pharmaceutical, and laboratory equipment. This diversification helps the company to capture multiple revenue streams and reduce dependence on a single market.

The company heavily invests in research and development activities, enabling it to continuously introduce new and advanced products to the market. This fosters innovation and keeps Sartorius AG at the forefront of technological advancements.

Weaknesses

Sartorius AG's financial performance is influenced by global economic conditions and market fluctuations. During economic downturns, the demand for its products may decrease, impacting the company's revenue and profitability.

While Sartorius AG has a strong brand reputation, it may have limited market presence compared to some of its competitors. This may restrict its market share and potential growth opportunities in certain geographic regions.

Opportunities

The biopharmaceutical industry is experiencing significant growth, driven by factors such as increasing research activities, rising investments in healthcare, and advancements in personalized medicine. Sartorius AG can capitalize on this trend by providing specialized equipment and solutions to meet the growing demand.

Expansion into emerging markets, such as Asia-Pacific and Latin America, can provide Sartorius AG with new growth opportunities. These regions have a growing biotechnology and pharmaceutical sector, creating a potential market for the company's products.

Threats

The industry in which Sartorius AG operates is highly competitive, with numerous players vying for market share. The company faces competition from both established companies and new entrants, which can pose challenges to its market position.

The biopharmaceutical industry is subject to strict regulatory requirements, and non-compliance can lead to penalties and reputational damage. Sartorius AG needs to continually ensure compliance with regulations and industry standards to mitigate legal risks.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Sartorius Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Sartorius historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Sartorius shares outstanding

The number of shares was Sartorius in 2023 — This indicates how many shares 68.416 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sartorius earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sartorius's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sartorius’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sartorius's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sartorius stock splits

In Sartorius's history, there have been no stock splits.

Sartorius dividend history and estimates

In 2023, Sartorius paid a dividend amounting to 1.43 EUR. Dividend means that Sartorius distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Sartorius provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Sartorius’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Sartorius's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Sartorius Dividend History

DateSartorius Dividend
2029e1.85 undefined
2028e1.85 undefined
2027e1.85 undefined
2026e1.85 undefined
2025e1.85 undefined
2024e1.85 undefined
20231.43 undefined
20221.25 undefined
20210.7 undefined
20200.35 undefined
20190.61 undefined
20180.5 undefined
20170.45 undefined
20160.38 undefined
20150.27 undefined
20140.25 undefined
20130.24 undefined
20120.2 undefined
20110.15 undefined
20100.1 undefined
20090.1 undefined
20080.17 undefined
20070.16 undefined
20060.13 undefined
20050.1 undefined
20040.06 undefined

Sartorius dividend payout ratio

In 2023, Sartorius had a payout ratio of 13.01%. The payout ratio indicates the percentage of the company's profits that Sartorius distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Sartorius represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Sartorius could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Sartorius's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Sartorius Payout Ratio History

DateSartorius Payout ratio
2029e13.22 %
2028e13.18 %
2027e13.27 %
2026e13.2 %
2025e13.05 %
2024e13.55 %
202313.01 %
202212.61 %
202115.02 %
202011.39 %
201926.62 %
201824.19 %
201726.82 %
201624.92 %
201514.4 %
201435.21 %
201330.52 %
201228.17 %
201120.27 %
201022.22 %
2009-90.91 %
200891.67 %
200735.23 %
200629.07 %
200531.25 %
200427.27 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Sartorius.

Sartorius latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.12 0.87  (-22.4 %)2024 Q3
6/30/20240.9 1.14  (26.82 %)2024 Q2
12/31/20231.36 0.95  (-30.33 %)2023 Q4
9/30/20231.3 1.04  (-20.18 %)2023 Q3
6/30/20231.92 1.26  (-34.34 %)2023 Q2
3/31/20232.21 1.69  (-23.42 %)2023 Q1
12/31/20221.71 2.24  (31.23 %)2022 Q4
9/30/20222.3 2.45  (6.39 %)2022 Q3
6/30/20222.28 2.44  (6.9 %)2022 Q2
3/31/20222.22 2.44  (9.81 %)2022 Q1
1
2
3

Eulerpool ESG Scorecard© for the Sartorius stock

Eulerpool World ESG Rating (EESG©)

92/ 100

🌱 Environment

91

👫 Social

99

🏛️ Governance

86

Environment

Scope 1 - Direct Emissions
17,939
Scope 2 - Indirect emissions from purchased energy
53,886
Scope 3 - Indirect emissions within the value chain
1,091,049
Total CO₂ emissions
71,825
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees38.9
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Sartorius shareholders

%
Name
Stocks
Change
Date
25.04562 % Franken Family18,754,16002/7/2024
17.34495 % Bio Rad Laboratories Inc12,987,90002/7/2024
1.14273 % Sartorius Herbst (Karin)855,67302/7/2024
0.78636 % Norges Bank Investment Management (NBIM)588,827-315,6026/30/2024
0.12422 % Carmignac Gestion93,01408/31/2024
0.11050 % ProfitlichSchmidlin AG82,7468,1617/31/2024
0.09881 % The Vanguard Group, Inc.73,9875,3659/30/2024
0.06551 % APG Asset Management N.V.49,0577,34712/31/2023
0.06423 % Florida State Board of Administration48,09348,0936/30/2024
0.05896 % California Public Employees' Retirement System44,149-1,7496/30/2023
1
2
3
4
5
...
8

Sartorius Executives and Management Board

Dr. Joachim Kreuzburg

(58)
Sartorius Chairman of the Executive Board, Chief Executive Officer, Interim Chief Financial Officer
Compensation 1.78 M

Dr. Rene Faber

(48)
Sartorius Member of the Executive Board, Head - Bioprocess Solutions Division
Compensation 906,000

Dr. Alexandra Gatzemeyer

(44)
Sartorius Member of the Executive Board, Head - Lab Products & Services division
Compensation 377,000

Dr. Lothar Kappich

(67)
Sartorius Chairman of the Supervisory Board, Shareholder Representative (since 2007)
Compensation 281,000

Mr. Manfred Zaffke

(67)
Sartorius Vice Chairman of the Supervisory Board, Employee Representative (since 2014)
Compensation 201,000
1
2
3

Sartorius Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
GVS Stock
GVS
SupplierCustomer0,87-0,050,460,910,840,32
Bio-Rad Laboratories A Stock
Bio-Rad Laboratories A
SupplierCustomer0,770,810,900,960,910,93
Adimmune Stock
Adimmune
SupplierCustomer0,68-0,120,320,740,66-0,39
Sartorius Stedim Biotech Stock
Sartorius Stedim Biotech
SupplierCustomer0,640,560,800,950,910,93
Eiwa Stock
Eiwa
SupplierCustomer0,580,400,65-0,470,510,67
Waters Stock
Waters
SupplierCustomer0,44-0,020,110,770,890,82
908 Devices Stock
908 Devices
SupplierCustomer0,09-0,060,490,700,76
Mabion Stock
Mabion
SupplierCustomer -0,520,360,940,720,63
Evotec Stock
Evotec
SupplierCustomer-0,09-0,360,240,890,740,81
Ampio Pharmaceuticals Stock
Ampio Pharmaceuticals
SupplierCustomer-0,62-0,460,750,820,780,43
1

Most common questions regarding Sartorius

What values and corporate philosophy does Sartorius represent?

Sartorius AG represents a set of values and corporate philosophy focused on innovation, quality, and sustainability. As a leading international laboratory and pharmaceutical equipment provider, Sartorius AG ensures customer satisfaction by continually developing cutting-edge technologies and maintaining the highest standards of product excellence. With a strong commitment to sustainability, the company aims to create long-term value for its stakeholders, including customers, employees, and investors. Sartorius AG's dedication to ethical practices, collaboration, and social responsibility underpins its mission to contribute to the progress of science and the betterment of society.

In which countries and regions is Sartorius primarily present?

Sartorius AG, a leading biotechnology and laboratory equipment provider, is primarily present in various countries and regions worldwide. The company's global footprint extends across major markets, including North America, Europe, Asia-Pacific, and Latin America. With its headquarters in Goettingen, Germany, Sartorius AG maintains a strong presence in its home country, serving as a hub for research and production. Moreover, the company has established subsidiaries and offices in key countries such as the United States, China, Japan, France, and many others, enabling Sartorius AG to cater to a diverse customer base and foster strategic collaborations on a global scale.

What significant milestones has the company Sartorius achieved?

Sartorius AG, a renowned company in the stock market, has accomplished several significant milestones. With a strong focus on precision and excellence, Sartorius AG has achieved remarkable growth and recognition over the years. Some noteworthy achievements include expanding its global presence by establishing subsidiaries and offices in key markets, continuously innovating and launching breakthrough products, and solidifying strategic partnerships with leading industry players. Sartorius AG has also received prestigious awards for its cutting-edge technology and outstanding performance in the life sciences and biopharmaceutical sectors. Through its dedication to quality and customer satisfaction, Sartorius AG has established itself as a trusted and forward-thinking company in the stock market.

What is the history and background of the company Sartorius?

Sartorius AG is a renowned German company with a rich history and background. Founded in 1870, Sartorius specializes in manufacturing and distributing laboratory and process technologies. With a strong focus on biopharmaceutical research and production, the company is widely recognized for its innovative solutions in filtration, weighing, and separation technologies. Sartorius AG has expanded globally and established a strong presence in over 110 countries, catering to a diverse range of industries such as food, healthcare, and biotechnology. With a legacy of excellence, Sartorius AG continues to be a leading provider of cutting-edge scientific instruments and services.

Who are the main competitors of Sartorius in the market?

The main competitors of Sartorius AG in the market include Thermo Fisher Scientific, Danaher Corporation, and Merck KGaA.

In which industries is Sartorius primarily active?

Sartorius AG is primarily active in the life sciences industry.

What is the business model of Sartorius?

The business model of Sartorius AG, a renowned company in the stock market, revolves around providing innovative and high-quality products and solutions for biopharmaceutical research and manufacturing. Sartorius AG specializes in the fields of laboratory instruments, consumables, and services, catering to the needs of pharmaceutical and biotech companies worldwide. With a strong focus on bioprocessing technologies, Sartorius AG enables its customers to efficiently develop and produce medications. Through continuous advancements in technology and a customer-oriented approach, Sartorius AG has established itself as a leading supplier in the life science industry, contributing significantly to the advancement of healthcare.

What is the P/E ratio of Sartorius 2024?

The Sartorius P/E ratio is 38.94.

What is the P/S ratio of Sartorius 2024?

The Sartorius P/S ratio is 3.54.

What is the Quality Investing of Sartorius?

The Quality Investing for Sartorius is 4/10.

What is the revenue of Sartorius 2024?

The expected Sartorius revenue is 3.4 B EUR.

How high is the profit of Sartorius 2024?

The expected Sartorius profit is 308.86 M EUR.

What is the business model of Sartorius

Sartorius AG is a global provider of innovative technologies and solutions for biopharmaceuticals, as well as for laboratory, food, and environmental applications. The company has two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions supplies the necessary technologies and products for the production of biopharmaceuticals, including filtration systems, disposable bioreactors, peristaltic pumps, and process control systems. Lab Products & Services offers innovative laboratory instrumentation and consumables for research, development, quality assurance, and control. The company is known for its use of disposable systems in biopharmaceuticals, which ensure process sterility and reduce cleaning and validation efforts. The company is focused on innovation and customer orientation to remain competitive in a rapidly changing global market. It invests in research and development to offer the most future-proof and efficient technologies and solutions to its customers. Overall, Sartorius operates in a growing industry driven by an increase in global patient data, the rising demand for personalized medicine, and the need for more efficient production processes.

What is the Sartorius dividend?

Sartorius pays a dividend of 1.25 EUR distributed over 1 payouts per year.

How often does Sartorius pay dividends?

Sartorius pays out a dividend 1 times a year.

What is the Sartorius ISIN?

The ISIN of Sartorius is DE0007165607.

What is the Sartorius WKN?

The WKN of Sartorius is 716560.

What is the Sartorius ticker?

The ticker of Sartorius is SRT.DE.

How much dividend does Sartorius pay?

Over the past 12 months, Sartorius paid a dividend of 1.43 EUR . This corresponds to a dividend yield of about 0.81 %. For the coming 12 months, Sartorius is expected to pay a dividend of 1.85 EUR.

What is the dividend yield of Sartorius?

The current dividend yield of Sartorius is 0.81 %.

When does Sartorius pay dividends?

Sartorius pays a quarterly dividend. This is distributed in the months of April, April, April, May.

How secure is the dividend of Sartorius?

Sartorius paid dividends every year for the past 26 years.

What is the dividend of Sartorius?

For the upcoming 12 months, dividends amounting to 1.85 EUR are expected. This corresponds to a dividend yield of 1.05 %.

In which sector is Sartorius located?

Sartorius is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sartorius kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sartorius from 4/4/2024 amounting to 0.73 EUR, you needed to have the stock in your portfolio before the ex-date on 4/2/2024.

When did Sartorius pay the last dividend?

The last dividend was paid out on 4/4/2024.

What was the dividend of Sartorius in the year 2023?

In the year 2023, Sartorius distributed 1.25 EUR as dividends.

In which currency does Sartorius pay out the dividend?

The dividends of Sartorius are distributed in EUR.

All fundamentals about Sartorius

Our stock analysis for Sartorius Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sartorius Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.